Login / Signup

CXCR4 S338X clonality is an important determinant of ibrutinib outcomes in patients with Waldenström macroglobulinemia.

Joshua N GustineLian XuNicholas TsakmaklisMaria G DemosAmanda KofidesJiaji G ChenXia LiuManit MunshiMaria Luisa GuerreraGloria G ChanChristopher J PattersonAndrew KeezerKirsten MeidToni DubeauGuang YangZachary R HunterSteven P TreonJorge J Castillo
Published in: Blood advances (2020)
Keyphrases
  • chronic lymphocytic leukemia
  • cell migration
  • type diabetes
  • metabolic syndrome
  • adipose tissue